Hoth Therapeutics, Inc. (HOTH) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 22 transactions totaling $1.0M, demonstrating a bearish sentiment with -$975.4K in net insider flow. The most recent transaction on Aug 28, 2025 involved a transaction of 310,744 shares valued at $376.0K.
No significant insider buying has been recorded for HOTH in the recent period.
No significant insider selling has been recorded for HOTH in the recent period.
Based on recent SEC filings, insider sentiment for HOTH is bearish with an Insider Alignment Score of 2/100 and a net flow of -$975.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Hoth Therapeutics, Inc. (HOTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading HOTH stock, having executed 22 transactions in the past 90 days. The most active insider is Anthony Hayes (Executive), who has made 5 transactions totaling $500.0K.
Get notified when executives and directors at HOTH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | Knie Robb | Executive | Payment | 310,744 | $1.21 | $376.0K | |
| Aug 27, 2025 | Knie Robb | Executive | Award | 800,000 | $N/A | $0 | |
| Aug 16, 2024 | Knie Robb | Executive | Purchase | 25,000 | $0.67 | $16.8K | |
| Dec 13, 2022 | Pavell Jeff | Executive | Award | 5,075 | $N/A | $0 | |
| Sep 19, 2022 | Knie Robb | Executive | Purchase | 10,000 | $0.39 | $3.9K | |
| Sep 16, 2022 | Knie Robb | Executive | Purchase | 10,000 | $0.40 | $4.0K | |
| May 26, 2020 | Hayes Anthony | Executive | Sale | 0 | $N/A | $0 | |
| May 26, 2020 | Inc. Aikido Pharma | Executive | Sale | 400,000 | $1.25 | $500.0K | Large |
| May 26, 2020 | Hayes Anthony | Executive | Sale | 400,000 | $1.25 | $500.0K | Large |
| May 18, 2020 | Knie Robb | Executive | Other | 4 | $N/A | $0 | |
| Apr 15, 2020 | Springer Graig | Executive | Award | 3,333 | $N/A | $0 | |
| Apr 15, 2020 | Linsley Wayne | Executive | Award | 3,333 | $N/A | $0 | |
| Nov 8, 2019 | Hayes Anthony | Executive | Other | 9,226 | $N/A | $0 | |
| Nov 8, 2019 | Spherix Inc | Executive | Other | 9,226 | $N/A | $0 | |
| Oct 28, 2019 | Hayes Anthony | Executive | Other | 90,258 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 3 | $1.0M | 71.4% |
Payment(F) | 1 | $376.0K | 26.8% |
Purchase(P) | 5 | $24.6K | 1.8% |
Award(A) | 4 | $0 | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Conversion(C) | 2 | $0 | 0.0% |
Insider selling pressure at Hoth Therapeutics, Inc. has increased, with 9 insiders executing 22 transactions across all time. Total sales of $1.0M significantly outpace purchases of $24.6K, resulting in a net outflow of $975.4K. This selling activity appears largely discretionary, which may warrant closer attention from investors.